At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Canada based CFO’ operating in the Health Care space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Sean Washchuk
Senior Vice President and Chief Financial Officer of CCL Industries
Sean Washchuk joined CCL in 2011 as Senior Vice President and Chief Financial Officer of CCL Industries Inc. Throughout his career, Washchuk has served in a variety of financial roles with increasing responsibility, including 11 years at Vitran Corporation Inc. as Vice President, Finance and Chief Financial Officer and Corporate Controller. Prior to Vitran, Washchuk was Controller for Nexcycle Plastics and acquired auditing experience at PricewaterhouseCoopers LLP. An accomplished CFO, Washchuk has extensive experience in corporate financial reporting, tax, treasury, international financing structures and acquisitions. Washchuk is a Chartered Accountant and graduated from Brock University with an Honours Bachelor of Accounting degree.
Follow Sean Washchuk:
About CCL Industries: CCL is the largest label company in the world and provides innovative solutions.
Inder Saini
Chief Financial Officer of Kovo HealthTech Corporation
Inder Saini is the Chief Financial Officer at Kovo HealthTech Corporation.
Follow Inder Saini:
About Kovo HealthTech Corporation: Kovo HealthTech is in healthcare technology and Revenue Cycle Management services.
Sara Oates
Vice President, Finance & Administration and Chief Financial Officer of WWF Canada
In her current role, Sara is responsible for finance, human resources, information technology, administration and operations. Prior to joining WWF-Canada, she worked for a Big Four accounting firm where she led its not-for-profit practice in Toronto. She is a chartered accountant, qualified in both England and Canada. During her career in public accounting, Sara worked with public companies and owner-managed businesses before specializing in the not-for-profit field in 2003. In this role, she was fortunate to work with a variety of organizations in the sector: from large international fundraisers to small start-up charities and membership organizations. Sara and her husband Andy have five children. Conservation and wildlife have always been close to her heart and never more so when seeing the importance of nature and the animal kingdom to her children. She and her family are active community volunteers. She is currently a member of the Audit and Administration Committee of the United Way Toronto and was the treasurer of a local children’s mental health agency and women’s shelter for nine years.
Follow Sara Oates:
About WWF Canada: For half a century, WWF has worked to protect the future of nature. WWF is Canada’s largest international conservation organization
Nizar Bharmal
Chief Financial Officer of Aurin Biotech
Nizar Bharmal is a renowned Certified General Accountant with over 30 years of well-merited accomplishments in his field. He was granted the professional designation of CGA in 1980. Early in his career he worked in the real estate development and investment field. From 1982 until 1985 Mr. Bharmal was Manager of the Bomarc Group, a management company providing services for reporting companies. In 1985, Mr. Bharmal passed the Canadian Securities Course with honors and founded Nizar Bharmal Inc. as a public practice dedicated to providing an array of accounting services, including Canadian and US taxation, financial consulting and corporate management for reporting companies. During his career, he has served as CEO and CFO for several publicly listed companies, where he has gained deep insight into both operations and regulatory affairs. Mr. Bharmal’s extensive association with and commitment to local business communities has resulted in admiration and confidence from many of his colleagues.
Follow Nizar Bharmal:
About ArcPacific Resources, Aurin Biotech: Aurin Biotech Inc. is a private company established to advance the development of a remarkable collection of small molecules.
Vasco Larcina. CPA
Chief Financial Officer of Lumira Ventures
Contributing over 20 years of senior financial management and audit experience, Vasco is a key member of senior management working closely with our investment team, external auditors and other finance professionals and acting as the primary point of contact for our limited partners. Having worked through the re-organization of the company and the disposition of the retail segment of the business, Vasco now focuses on the growth of the institutional fund management business, the streamlining of finance and legal operations and external reporting to our limited partners. Responsible for the financial management of Lumira Ventures and the investment funds it manages, Vasco oversees financial and legal operations, ensuring that the appropriate controls are in place to manage the activities of Lumira Ventures and its managed funds through the strategic evaluation, development and implementation of financial policies, systems and procedures developed in consideration of external reporting, risk and governance as well as regulatory and tax compliance. Prior to joining Lumira Ventures, Vasco worked as an external auditor with KPMG and has gained internal audit and operational audit experience with a regulated public utility where he provided the internal control input for a major customer information system development project.
Follow Vasco Larcina. CPA:
About Lumira Ventures: Canada’s leading health care & life sciences venture capital firm with a 30-year reputation building companies across North America.
Torindo Panetta
Chief Financial Officer of Canadian Medical Association
Torindo Panetta is Chief Financial Officer at Canadian Medical Association
Follow Torindo Panetta:
About Canadian Medical Association: The Canadian Medical Association (CMA) is a national, voluntary association of physicians that advocates on behalf of its members.
Raj Kailasanathan
CFO of PopRx Inc.
Follow Raj Kailasanathan:
About PopRx Inc.: A better pharmacy experience offered via web, mobile and digital technologies to empower healthcare and patient health outcomes.
Raj Kailasanathan
CFO of PopRx Inc.
Follow Raj Kailasanathan:
About PopRx Inc.: A better pharmacy experience offered via web, mobile and digital technologies to empower healthcare and patient health outcomes.
Bill Mantzoutsos
Chief Financial Officer & Director of JADE Healthcare Group Inc.
Co-Founder of JADE Healthcare Group.
Follow Bill Mantzoutsos:
About JADE Healthcare Group Inc.: Intelligent Cloud Computed Health Monitoring
Tania M Clarke
Senior Vice President & CFO of New Look Vision Group
Follow Tania M Clarke:
About New Look Vision Group: New Look Vision Group is a provider of eye care products and services in Eastern Canada.
Kimberly Stephens
Chief Financial Officer of Appili Therapeutics
Kimberly Stephens joined Appili Therapeutics as Chief Financial Officer in 2016.
Follow Kimberly Stephens:
About Appili Therapeutics: Appili Therapeutics is an anti-infective pharmaceutical development company.
Kim Carroll
Chief Financial Officer of HealthHub Patient Engagement Solutions
Ms. Carroll is a Chartered Professional Accountant, Certified Management Accountant. Ms. Carroll started her career at Health Canada, holding several roles from accounting clerk to Finance Officer, within the Indian Health Benefits Unit. In 1998, she was hired by SaskTel as an accountant. She held various roles in accounting in the product costing area, as well as the corporate accounting group. In 2001, she was promoted Corporate Accounting Manager – responsible for the financial reporting of SaskTel’s consolidated operations. In 2006, she moved to the role of Asset Management Manager – responsible for the reporting of over $2.5B in assets for the company. In 2007, she was seconded to HN to fill the role of VP Finance. In 2011, she left SaskTel to fill the role of CFO & Secretary for HN under the new ownership of PFM Capital.
Follow Kim Carroll:
About HealthHub Patient Engagement Solutions: HHPES is a provider of entertainment and communication services in the Canadian healthcare market.
Patrick Montpetit
Partner and Chief Financial Officer of NuChem Sciences
Patrick Montpetit has over fifteen years of experience in senior financial management positions. He is a chartered accountant, specializing in corporate finance and has extensive experience in the life sciences and biopharmaceutical industries. Prior to joining Immunotec, Mr. Montpetit served as Vice-President, Finance and Chief Financial Officer of Bioniche Life Sciences Inc. and Director of Finance, Administration, Commercial Agreements and Alliances with DSM Biologics Inc. His professional experience includes serving as Chairman of the Quebec Biotechnology Association and Director of the Montreal InVivo organization.
Follow Patrick Montpetit:
About NuChem Sciences: NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal.
Michael English
Chief Financial Officer of Alternate Health
Mike English has over 30 years’ experience working in diverse industries including data security and encryption software, telecommunications, and heavy industrial electric motors and controls. Ten of those years were with a leading software as a service (SAAS) public encryption company where he served as controller and CFO. Under Mike’s leadership, the company drastically improved earnings and cash flow while reducing the company’s risk profile and improving compliance. They achieved best in class public company audit committee ISS governance ratings. As a Vice President of Finance and Controller in the telecommunications and heavy industrial electric motors and controls industries, Mike managed large groups including director level direct reports in multi-locations, both domestic and international (US, Canada, UK, Germany, Italy and Israel). In addition to accounting and reporting responsibilities, a major part of his role included implementing and integrating enterprise wide software (SAP) across several manufacturing divisions. Over a career that spans auditing, controllership, financial systems and senior executive financial management, Mike’s experience reaches across technical accounting, financial reporting and disclosure controls, risk avoidance, multi-location, SEC reporting, public company corporate governance, equity compensation, manufacturing cost accounting and includes HR and benefits, IT, facilities management and strategy. Mike earned a BA in English with a concentration in business from John Carroll University and an MS in Accountancy from DePaul University. He is a CPA and is a member of the Ohio Society of CPA’s.
Follow Michael English:
About Alternate Health: Alternate Health is a healthcare investment company specializing in the software development for the healthcare industry.
Philip Van Den Berg
Chief Financial Officer of Namaste Technologies
Follow Philip Van Den Berg:
About Namaste Technologies: Lifeist is a wellness company
Pascal Tessier-Fleury
General Manager & CFO of PetalMD
Pascal Tessier-Fleury is a VP Finance at PetalMD.
Follow Pascal Tessier-Fleury:
About PetalMD: PetalMD is a leader in the development of online management, communication and planning tools intended for physicians.
Simon Buckett
CFO of HealthTech Connex
Mr. Buckett brings with him over twelve years of finance and project management experience working for private and publicly listed companies in the UK, US, and Canada. Mr. Buckett began his career with KPMG in London and then in Vancouver as Senior Auditor, later joining Ernst & Young as an audit department Manager. Most recently he was Vice President of Finance at Wurldtech Security Technologies, Inc. His responsibilities have included internal control and governance policy, the implementation of Sarbanes-Oxley in a number of SEC registrants, and managing the reporting requirements of a range of private and public companies.
Follow Simon Buckett:
About HealthTech Connex: HealthTech Connex focuses on technology-based innovations for health improvements and outcomes.
Justine Jackson
Executive Vice President & Chief Financial Officer of University Health Network
As Executive Vice President & Chief Financial Officer of the University Health Network (UHN), Justine Jackson is responsible for managing the organization’s $1.9 billion annual operating budget and is accountable for the Corporate Planning, Decision Support, Finance, Infrastructure, Joint Department of Medical Imaging and Strategic Developments portfolios. Justine joined UHN in 1985 and progressed through a number of management positions including executive director of Operations for the Neuroscience as well as the Musculoskeletal Health and Arthritis Programs. Her career highlights include the due diligence and financial consolidation of the mergers over time between Toronto General Hospital, Princess Margaret Hospital, Toronto Western Hospital, Doctor’s Hospital and the Toronto Rehab Institute, which together constitute Canada’s premier academic and research healthcare facility. Her implementation of case costing at UHN was foundational to understanding UHN’s financial and clinical integration. Justine’s external experience includes membership on several funding reform advisory committees at the Ministry of Health and Long-Term Care, and the Council of Academic Hospitals of Ontario. She is a member of the Booth Centennial Board of Directors. Justine also sits on several Board committees for UHN, the Toronto General & Western Hospital Foundation and Plexxus. She is a guest lecturer at the University of Toronto’s engineering faculty, and UHN’s Rotman Program at the University of Toronto.
Follow Justine Jackson:
About University Health Network, University of Toronto, University of Toronto: UHN is a research hospital in cardiology, transplantation,surgical innovation, infectious diseases rehabilitation medicine and more.
Bruno Kaiser
Chief Financial Officer of Smile CDR
Bruno Kaiser is the Chief Financial Officer at Smile CDR.
Follow Bruno Kaiser:
About Smile CDR: Smile CDR specializes in delivering fast, secure, compliant data infrastructures to enable for data intensive sectors such as healthcare.
James Kinley
Chief Financial Officer of FGC Health
James Kinley is the Chief Financial Officer at FGC Health.
Follow James Kinley:
About FGC Health, Luminor Medical Technologies: FGC Health is devoted to serving as an ownership bridge to a new generation of pharmacists.
Thomas Kordyback
Chief Financial Officer of RepliCel Life Sciences
Tom Kordyback is a Chartered Accountant and a member of the British Columbia Institute of Chartered Accountants with over 25 years of experience in corporate finance and management for emerging growth companies. From 1984 to 1994, he held senior financial positions with Glenayre Electronics Inc. and Telelink Communications Inc. and worked as a consultant to other Vancouver area companies. In 1995, he began working for Creo, now part of Eastman Kodak Company as their Chief Financial Officer. In this role he oversaw private financings totally over $80 million and in 1999 he led the company’s Initial Public Offering on NASDAQ. He remained at Creo until 2000; at which time, the company had over 4000 employees worldwide. In 2004, Mr. Kordyback joined Extreme CCTV Inc., a developer and manufacturer of state-of-the-art surveillance systems listed on the TSX. He worked for them for three years as a director and member of its Audit, Compensation and Merger and Acquisitions Committees. In 2008 the company was sold to Bosch Security Systems, Inc. for CDN $93 million. Mr. Kordyback currently serves as a director of Silver Sun Resources Corp., a public Canadian-based resource company.
Follow Thomas Kordyback:
About RepliCel Life Sciences: RepliCel Life Sciences is a regenerative medicine company using cell therapy products for healing tendinosis, aging, and pattern baldness.
Yacine Amrani
CFO of Glycovax Pharma
Follow Yacine Amrani:
About Glycovax Pharma, Massfilter, Travoom: Glycovax Pharma focuses on developing nano-medicines to treat cancers and other diseases.
Nate Tchaplia
Chief Financial Officer of Dental Corp
Nate Tchaplia is the Chief Financial Officer at Dental Corp.
Follow Nate Tchaplia:
About Dental Corp: Revolutionize the business of dentistry
Ann Fehr
CFO of Aequus Pharmaceuticals
Fehr is the Principal at Fehr & Associates, and has held a number of senior level positions including having served as CFO of Carrus Capital Corporation (formerly BioWest Therapeutic Inc.), Global Minerals Ltd., and other companies listed on the TSX. During the course of her management and consulting career, Ms. Fehr has led a number of companies through significant change and corporate milestones such as public listing applications, mergers and acquisitions, as well as strategic planning and execution. Ms. Fehr is also an active volunteer in the community. Since 2013, she has been Treasurer and a Director for the Boys and Girls Clubs of South Coast BC.
Follow Ann Fehr:
About Aequus Pharmaceuticals: Aequus Pharmaceuticals is a pharmaceutical company that focuses on therapeutic areas, including neurology, ophthalmology, and transplant.
David Prue
Chief Financial Officer of Oxy Bump Corporation
David Prue brings crucial start-up specific knowledge and experience, having worked with companies to and through their public offerings. His public company directorship, capital raising, and start-up business development skills are a valuable contribution to the Oxy Bump team. David’s expertise in financial management, administration and strategic/financial planning are rounded out by an operational understanding of inventory management, operations planning and execution, and corporate administration. As an environmental proponent, David has actively sought out and worked with early stage companies with a global consciousness and positive social impact. His prior experiences include companies with offerings of diversion and organic recycling as well as alternative energy solutions.
Follow David Prue:
About Oxy Bump Corporation: Oxy Bump’s distinctive line of products are the only oxygen-infused nasal/throat sprays in mass market.
David Long
Chief Financial Officer of BioVectra
David Long is the Chief Financial Officer of BioVectra. He has over 30 years of experience in Finance and IT leadership, including the CDMO space. He obtained an MBA in Finance and International Business from Dalhousie University.
Follow David Long:
About BioVectra: BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients.
Mark Leung
CFO of Aereus Technologies
Follow Mark Leung:
About Aereus Technologies: Aereus is a pioneer in the global metallic antimicrobial coating industry.
Mark Leung
CFO of Aereus Technologies
Follow Mark Leung:
About Aereus Technologies: Aereus is a pioneer in the global metallic antimicrobial coating industry.
Akmal Jameel
Chief Financial Officer of Fusion Genomics Corporation
Follow Akmal Jameel:
About Fusion Genomics Corporation, SensoDrive Technology: Fusion Genomics develops highly sensitive and massively multiplex DNA/RNA sequencing based diagnostics for infectious diseases.
George Dorin
Chief Financial Officer & Corporate Secretary of Pyng Medical
Mr. Dorin has 30 years of broad-based financial experience, including 15 years as a Corporate Director or CFO for several private and public companies. He holds undergraduate degrees in Science and Accounting from the University of BC, a Masters Degree in Finance from the London School of Economics, and the Diploma FCSI (Fellow of the Canadian Securities Institute). A Chartered Accountant, he was also granted a CF (Corporate Finance) specialist designation from the CICA in 2008. Prior to his work in industry, he worked in the financial services sector with Ernst & Whinney (now KPMG), Price Waterhouse, Royal Bank of Canada, and with Pemberton Securities (now RBC Dominion Securities). In 2007 and 2008 he was a Senior VP Corporate Finance at Wolrige Mahon, a BC-based CA Firm. Most recently, he has been providing corporate finance, senior financial management and corporate director (including audit committee chairman) services to several industrial public companies through this own company CANUS Capital Corporation.
Follow George Dorin:
About Pyng Medical: Pyng Medical develops trauma and resuscitation products for the health care industry.
Noel Castillo
Chief Financial Officer of World Wide Hearing Foundation International
Noel is responsible for World Wide Hearing’s banking, accounting, cash flow management and handling external audits. He holds a B.Econ. from Universidad Panamerica and a master’s degree in finance from Universitat de Barcelona. In December 2014, Noel passed the CFA (Chartered Financial Analyst) level I exam. His previous experience includes working as a Latin America treasury analyst for PepsiCo Mexico (where he received the 2010 Sabritas award for capturing $3.2M MXN in NOPBT savings), as well as working in trustee services for Banamex-Citigroup. Prior to joining World Wide Hearing, Noel was an active volunteer at several non-profit organizations in Montreal.
Follow Noel Castillo:
About World Wide Hearing Foundation International: Providing access to aff ordable hearing aids for children in developing countries.
Branko Jankovic
VP & CFO of Ceapro
Follow Branko Jankovic:
About Ceapro: Ceapro is into developing functionally active ingredients derived from oats and renewable plant resources for healthcare and cosmetic needs.
Randy Baughman
Chief Financial Officer of Kimble Chase Life Science and Research
Prior to joining Kimble Chase, Randy held increasing responsibilities at several multi-national corporations, most recently as CFO of Gerresheimer Glass, Inc. His responsibilities included finance, treasury, tax, and IT. Randy is also responsible for Global Supply Chain activities within Kimble Chase. Prior to Gerresheimer Glass. Inc., Randy was Financial Director for 10 years at Valeo Automotive, including a two year secondment in Sweden. He held functional and business management responsibilities for finance, treasury, tax, and IT at various divisions/locations within Valeo. Earlier in his career, Randy was a Staff Accountant for a local CPA firm, where he went on to earn his CPA certificate. Randy graduated from Penn State University with a BS degree in Accounting, Management and a minor in Economics.
Follow Randy Baughman:
About Kimble Chase Life Science and Research: Kimble Chase Life Science and Research is a leading producer of laboratory and scientific glassware.
Cameron Nelson
CFO of Mati Therapeutics
Cameron Nelson is the CFO at Mati Therapeutics.
Follow Cameron Nelson:
About Mati Therapeutics: Mati Therapeutics offers a delivery system to deliver drugs to the surface of the eye through the tear film.
Cameron Nelson
CFO of Mati Therapeutics
Cameron Nelson is the CFO at Mati Therapeutics.
Follow Cameron Nelson:
About Mati Therapeutics: Mati Therapeutics offers a delivery system to deliver drugs to the surface of the eye through the tear film.
Bruce Colwill
CFO of InMed Pharmaceuticals
Bruce Colwill is the Chief Financial Officer at InMed Pharmaceuticals.
Follow Bruce Colwill:
About InMed Pharmaceuticals: InMed Pharmaceuticals is a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates.
Scott Wilson
CFO of Evasc Neurovascular Enterprises
Follow Scott Wilson:
About Evasc Neurovascular Enterprises: Evasc Neurovascular is a privately held medical device company
Scott Wilson
CFO of Evasc Neurovascular Enterprises
Follow Scott Wilson:
About Evasc Neurovascular Enterprises: Evasc Neurovascular is a privately held medical device company
Sylvain Guénette
CFO of Labopharm
Follow Sylvain Guénette:
About Labopharm: Labopharm is an international, specialty pharmaceutical company focused on optimizing the performance of existing drugs.
Tak Wing Law
CFO of The Jenex Corporation
Tak Wing Law has over 20 years of experiences as a finance professional and business executive and has worked with various companies and professional firms in Canada, China and Hong Kong including Price Waterhouse, Law Society of Hong Kong etc. He is now the Director of Finance of Kingsdale Shareholder Services Inc., a transfer agent registered with US Securities Exchange Commission. Mr. Law has been involved in processing the transactions including merger and acquisition and plan of arrangement of publicly-traded companies. He also handles the corporate reporting and compliance including auditing, financial reporting, taxation and EDGAR filing. Before coming to Canada, he founded T W Law & Co. in 1996 specializing in corporate restructuring and bankruptcy and had been appointed as trustee of bankruptcy by the Court of First Instance of the High Court of Hong Kong. He has a Master of Arts from University of Oklahoma, U.S and Postgraduate Diplomas from Hong Kong Polytechnic University. Mr. Law is a Certified General Accountant, Chartered Accountant in England and Wales, a Certified Public Accountant in Hong Kong. He is also an associate member of Chartered Secretary Canada.
Follow Tak Wing Law:
About The Jenex Corporation: Jenex is a progressive medical technology company focused on providing consumers with quality dermatological products.